Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis

被引：0
|
作者：
J. Hillengass
A. D. Ho
H. Goldschmidt
R. Waldherr
T. M. Moehler
机构：
[1] University Hospital of Heidelberg,Department of Hematology, Oncology and Rheumatology
[2] Gemeinschaftspraxis Pathologie,undefined
来源：
International Journal of Hematology | 2008年 / 88卷
关键词：
Cryoglobulinemia; Multiple myeloma; Stem cell transplantation; Immune reset;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We present a case report of a patient with cryoglobulin-vasculitis caused by multiple myeloma in Durie/Salmon stage I refractory to conventional therapy modalities treated with high-dose chemotherapy followed by autologous blood stem cell transplantation. While clinical symptoms of vasculitis disappeared, elevated cryoglobulin levels persisted. Therefore we conclude that the relief of symptoms was caused by an immunomodulation induced by the autologous stem cell transplantation.
引用
收藏
页码：454 / 456
页数：2
相关论文
共 50 条
  • [1] Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis
    Hillengass, J.
    Ho, A. D.
    Goldschmidt, H.
    Waldherr, R.
    Moehler, T. M.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (04) : 454 - 456
  • [2] The efficacy of high-dose melphalan with autologous peripheral blood stem cell transplantation in patients with multiple myeloma
    Lee, JL
    Kim, SB
    Lee, GW
    Ryu, MH
    Kim, E
    Kim, S
    Kim, WK
    Lee, JS
    Kim, SH
    Suh, C
    YONSEI MEDICAL JOURNAL, 2003, 44 (05) : 800 - 810
  • [3] Achievement of Complete Remission After High-Dose Melphalan and Autologous Stem Cell Transplantation Is the Only Important Prognostic Factor in Patients with Multiple Myeloma
    Shin, Seunghwan
    Kim, Jeong-A
    Lee, Bohee
    Min, Chang Ki
    Kwak, Jae-Yong
    Yhim, Ho-Young
    BLOOD, 2011, 118 (21) : 882 - 883
  • [4] High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission
    E Nadal
    E Giné
    J Bladé
    J Esteve
    L Rosiñol
    F Fernández-Avilés
    P Marin
    C Martinez
    M Rovira
    A Urbano-Ispizua
    E Carreras
    E Montserrat
    Bone Marrow Transplantation, 2004, 33 : 61 - 64
  • [5] High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma:: predictors of complete remission
    Nadal, E
    Giné, E
    Bladé, J
    Esteve, J
    Rosiñol, L
    Fernández-Avilés, F
    Marin, P
    Martinez, C
    Rovira, M
    Urbano-Ispizua, A
    Carreras, E
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 2004, 33 (01) : 61 - 64
  • [6] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Alexandra Gomez-Arteaga
    Tomer M. Mark
    Danielle Guarneri
    Paul J. Christos
    Usama Gergis
    June D. Greenberg
    Jingmei Hsu
    Sebastian A. Mayer
    Ruben Niesvizky
    Roger N. Pearse
    Adrienne A. Phillips
    Adriana Rossi
    Morton Coleman
    Koen van Besien
    Tsiporah B. Shore
    Bone Marrow Transplantation, 2019, 54 : 2027 - 2038
  • [7] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Gomez-Arteaga, Alexandra
    Mark, Tomer M.
    Guarneri, Danielle
    Christos, Paul J.
    Gergis, Usama
    Greenberg, June D.
    Hsu, Jingmei
    Mayer, Sebastian A.
    Niesvizky, Ruben
    Pearse, Roger N.
    Phillips, Adrienne A.
    Rossi, Adriana
    Coleman, Morton
    van Besien, Koen
    Shore, Tsiporah B.
    BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2027 - 2038
  • [8] Long-term results in multiple myeloma treated with high-dose melphalan and autologous peripheral stem cell transplantation and achieving complete remission.
    Martino, Massimo Vincenzo
    Postorino, Maurizio
    Gallo, Giuseppe Alberto
    Irrera, Giuseppe
    Piro, Eugenio
    Messina, Giuseppe
    Neri, Santo
    Al Sayyad, Said
    Fedele, Roberta
    Musolino, Caterina
    Molica, Stefano
    Brugiatelli, Maura
    Nobile, Francesco
    Morabito, Fortunato
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Miyamoto, Toshihiro
    Yoshimoto, Goichi
    Kamimura, Tomohiko
    Muta, Tsuyoshi
    Takashima, Shuichiro
    Ito, Yoshikiyo
    Shiratsuchi, Motoaki
    Choi, Ilseung
    Kato, Koji
    Takenaka, Katsuto
    Iwasaki, Hiromi
    Takamatsu, Yasushi
    Teshima, Takanori
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (03) : 337 - 345
  • [10] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Toshihiro Miyamoto
    Goichi Yoshimoto
    Tomohiko Kamimura
    Tsuyoshi Muta
    Shuichiro Takashima
    Yoshikiyo Ito
    Motoaki Shiratsuchi
    Ilseung Choi
    Koji Kato
    Katsuto Takenaka
    Hiromi Iwasaki
    Yasushi Takamatsu
    Takanori Teshima
    Koichi Akashi
    International Journal of Hematology, 2013, 98 : 337 - 345
12345